Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Worm-Like Nanoparticles Used to Kill Breast Cancer Cells

By LabMedica International staff writers
Posted on 26 Dec 2013
Cylinder-shaped nanoparticles have been shown to be seven times more lethal than traditional spherical ones when delivering drugs to breast cancer cells, an international team of researchers has discovered.

Moreover, the worm-shaped drug delivery vehicles are not anymore toxic to healthy cells according to the study, which was published December 2013 in the journal Polymer Chemistry. In this study, different polymeric nanoparticle shapes (including spherical micelle, cylindrical micelle, and vesicles) were examined, and the early findings suggest shape plays an important role in the cell uptake and toxicity response. More...
The project was co-led by Assoc. Prof. Cyrille Boyer, from the University of New South Wales (UNSW) School of Chemical Engineering (Sydney, Australia) and the Australian Center for NanoMedicine (Sydney), and Prof. Thomas Davis from Monash University (Melbourne, Australia), and involved Dr. Bunyamin Karagoz from Istanbul Technical University (Turkey).

Developing nanoparticles to target drugs directly to specific regions of the body is an increasing field of medicine, and these new findings suggest changing the shape of nanoparticles could slash both treatment costs and side effects. “What we’ve discovered is that a different shaped nanoparticle can have a very different effect on cancer cells, even with the same amount of drug,” said Dr. Boyer. “However there is still a lot of work to do and we need to test the nanoparticles in vitro with a range of cancer cells.”

Research had earlier mostly focused on spherical drug delivery systems as they are easier to make, but this new study additionally offers a simple and inexpensive approach to devising three different nanoparticle shapes: vesicular, spherical, and tubular or “worm-like.”

The researchers are now looking into whether cylindrical shape nanoparticles also deliver drugs more effectively to other types of cancers.

Related Links:

University of New South Wales School of Chemical Engineering
Monash University
Istanbul Technical University



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Clinical Chemistry System
P780
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.